FI102168B1 - 3,6,9-Triaza-undecanoic acid derivatives and their salts - Google Patents

3,6,9-Triaza-undecanoic acid derivatives and their salts

Info

Publication number
FI102168B1
FI102168B1 FI903295A FI903295A FI102168B1 FI 102168 B1 FI102168 B1 FI 102168B1 FI 903295 A FI903295 A FI 903295A FI 903295 A FI903295 A FI 903295A FI 102168 B1 FI102168 B1 FI 102168B1
Authority
FI
Finland
Prior art keywords
represent
hydrogen atom
salts
denote
triaza
Prior art date
Application number
FI903295A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI102168B (en
FI903295A0 (en
Inventor
Heribert Schmitt-Willich
Johannes Platzek
Heinz Gries
Gabriele Schuhmann-Giampieri
Hubert Vogler
Hanns-Joachim Weinmann
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6384290&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI102168(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Publication of FI903295A0 publication Critical patent/FI903295A0/en
Application granted granted Critical
Publication of FI102168B1 publication Critical patent/FI102168B1/en
Publication of FI102168B publication Critical patent/FI102168B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/16—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C07F15/02—Iron compounds
    • C07F15/025—Iron compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic System
    • C07F5/003—Compounds containing elements of Groups 3 or 13 of the Periodic System without C-Metal linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/94—Bismuth compounds

Abstract

Compounds of the general formula <IMAGE> in which Z<1> and Z<2> each represent a hydrogen atom or the radical -(CH2)m-(C6H4)q-(O)k-(CH2)n(C6H4) l-(O)r-R, in which m and n denote the figures 0 - 20, k, l, q and r denote the figures 0 and 1 and R denotes a hydrogen atom, an unsubstituted or OR<1>-substituted C1-C6-alkyl radical or a CH2COOR<1> group where R<1> denotes a hydrogen atom, a C1-C6-alkyl radical or a benzyl group, X represents a hydrogen atom and/or a metal ion equivalent of an element of atomic number 21 - 29, 42, 44 or 57 - 83, with the proviso that at least two of the substituents X represent a metal ion equivalent in which one of the substituents Z<1> and Z<2> represents a hydrogen atom and the other does not represent a hydrogen atom, in which - if n and l each represent the figure 0 - k and r do not simultaneously each denote the figure 1, in which Z<1> or Z<2> do not represent -CH2-C6H4-O-CH2-COOCH2C6H5 or CH2-C6H4-O-(CH2)5-COOCH2C6H5 and in which -(O)r-R does not represent -OH, and their salts with inorganic and/or organic bases, amino acids or amino acid amides, are useful pharmaceutical agents.
FI903295A 1989-06-30 1990-06-29 3,6,9-triaza-undecanoic acid derivatives and their salts FI102168B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3922005A DE3922005A1 (en) 1989-06-30 1989-06-30 DERIVATIVED DTPA COMPLEXES, PHARMACEUTICAL AGENTS CONTAINING THESE COMPOUNDS, THEIR USE AND METHOD FOR THE PRODUCTION THEREOF
DE3922005 1989-06-30

Publications (3)

Publication Number Publication Date
FI903295A0 FI903295A0 (en) 1990-06-29
FI102168B1 true FI102168B1 (en) 1998-10-30
FI102168B FI102168B (en) 1998-10-30

Family

ID=6384290

Family Applications (1)

Application Number Title Priority Date Filing Date
FI903295A FI102168B (en) 1989-06-30 1990-06-29 3,6,9-triaza-undecanoic acid derivatives and their salts

Country Status (24)

Country Link
EP (1) EP0405704B1 (en)
JP (1) JP2603357B2 (en)
KR (1) KR100190808B1 (en)
AT (1) ATE115546T1 (en)
AU (1) AU637111B2 (en)
CA (1) CA2020142C (en)
CZ (1) CZ277926B6 (en)
DD (1) DD296276B5 (en)
DE (3) DE3922005A1 (en)
DK (1) DK0405704T3 (en)
ES (1) ES2066113T3 (en)
FI (1) FI102168B (en)
HK (1) HK1002810A1 (en)
HU (1) HU210208B (en)
IE (1) IE65676B1 (en)
IL (1) IL94818A (en)
NL (1) NL300182I2 (en)
NO (2) NO179203C (en)
NZ (1) NZ234295A (en)
PT (1) PT94541B (en)
RU (1) RU2086554C1 (en)
TW (1) TW219356B (en)
UA (1) UA27275C2 (en)
ZA (1) ZA905129B (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4011684A1 (en) 1990-04-06 1991-10-10 Schering Ag DTPA MONOAMIDES, PHARMACEUTICAL AGENTS CONTAINING THESE COMPOUNDS, THEIR USE AND METHOD FOR THE PRODUCTION THEREOF
DE4302289A1 (en) * 1993-01-25 1994-07-28 Schering Ag Process for the preparation of C-substituted diethylenetriamines
DE4302287A1 (en) * 1993-01-25 1994-07-28 Schering Ag Derivatized DTPA complexes, pharmaceutical compositions containing these compounds, their use and processes for their preparation
DE4341724A1 (en) * 1993-12-03 1995-06-08 Schering Ag Pharmaceutical compositions containing haloaryl-substituted metal complexes, their use in diagnostics, and methods for producing the complexes and compositions
US5582814A (en) * 1994-04-15 1996-12-10 Metasyn, Inc. 1-(p-n-butylbenzyl) DTPA for magnetic resonance imaging
HUT77553A (en) * 1994-11-30 1998-05-28 Schering Aktiengesellschaft Use of chelate compounds as diagnostic agents in the x-ray examination of liver and bile ducts
US5672335A (en) * 1994-11-30 1997-09-30 Schering Aktiengesellschaft Use of metal complexes as liver and gallbladder X-ray diagnostic agents
TW319763B (en) 1995-02-01 1997-11-11 Epix Medical Inc
WO1996024381A2 (en) * 1995-02-09 1996-08-15 Schering Aktiengesellschaft Liposomes containing contrast media for blood pool imaging
DE19507820A1 (en) * 1995-02-21 1996-08-22 Schering Ag Novel substituted DTPA derivatives, their metal complexes, pharmaceutical compositions containing these complexes, their use in diagnostics, and methods for producing the complexes and compositions
JP2759627B2 (en) * 1995-07-21 1998-05-28 東北大学長 Non-ester bondable DTPA derivative and method for producing the same
DE19641197C2 (en) * 1996-09-24 1999-02-18 Schering Ag Ion pairs and their use as contrast agents
DE19646762B4 (en) * 1996-11-04 2004-05-13 Schering Ag Use of metal compounds for the production of agents for radiotherapy of tumors
DE19712012A1 (en) * 1997-03-13 1998-09-24 Schering Ag Ethoxy:benzyl-di:ethylene tri:amine penta:acetic acid preparation
DE19744004C1 (en) * 1997-09-26 1999-07-22 Schering Ag Lipophilic metal complexes for necrosis and infarct imaging
US6495118B1 (en) 1997-09-26 2002-12-17 Schering Aktiengesellschaft Lipophilic metal complexes for necrosis and infarction imaging
US6534040B2 (en) * 1999-12-23 2003-03-18 Health Research, Inc. Chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
FR2867473B1 (en) 2004-03-12 2006-06-23 Guerbet Sa PORPHYRINE COMPOUND AND HIGH FIELD USE IN MRI
KR100749087B1 (en) * 2006-06-02 2007-08-14 경북대학교 산학협력단 New dtpa-bis-amide ligands and gd-complexes thereof
SE533165C2 (en) * 2008-06-13 2010-07-13 Chemseq Internat Ab Chemical and process for the complex bonding of metal ions, which are at least divalent
EP2338874A1 (en) * 2009-12-16 2011-06-29 Bracco Imaging S.p.A Process for the preparation of chelated compounds
SG186259A1 (en) 2010-06-11 2013-01-30 Bayer Ip Gmbh Process for preparing crystalline 3,6,9-triaza-3,6,9-tris(carboxymethyl)-4-(4-ethoxybenzyl)undecanedioic acid and use for production of primovist®
DE102010023890A1 (en) 2010-06-11 2011-12-15 Bayer Schering Pharma Aktiengesellschaft Preparing crystalline 3,6,9-triaza-3,6,9-tris(carboxymethyl)-4-(ethoxybenzyl)-undecanedioic acid comprises hydrolyzing 3,6,9-triaza-3,6,9-tris(tert-butoxy-carbonylmethyl)-4-(ethoxybenzyl)-undecanedioic acid-ditert-butylester and acidifying
CN104761461A (en) * 2014-09-09 2015-07-08 山东富创医药科技有限公司 Preparation method of novel gadoxetate disodium intermediate
EP3464237B1 (en) * 2016-05-30 2023-12-20 Biophore India Pharmaceuticals Pvt. Ltd. Novel process for the preparation of gadolinium complex of (4s)-4-(4-ethoxybenzyl)-3,6,9-tris(carboxylatomethyl)-3,6,9- triazaundecanedioic acid disodium (gadoxetate disodium)
JP6867639B2 (en) * 2016-10-11 2021-05-12 学校法人 聖マリアンナ医科大学 Combined nonionic iodine contrast agent
EP4059925A1 (en) 2021-03-15 2022-09-21 Bayer Aktiengesellschaft New contrast agent for use in magnetic resonance imaging
EP4335462A1 (en) 2022-09-09 2024-03-13 Bayer AG Contrast agents for use in diagnostic computed tomography imaging
EP4335840A1 (en) 2022-09-09 2024-03-13 Bayer Aktiengesellschaft New contrast agents for use in diagnostic imaging

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL194579C (en) * 1983-01-21 2002-08-05 Schering Ag Diagnostic.
US4672028A (en) * 1984-05-23 1987-06-09 Icn Micromedic Systems, Inc. Compositions and method for simultaneous multiple array of analytes using radioisotope chelate labels
US4824986A (en) * 1985-04-26 1989-04-25 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Metal chelate protein conjugate
IL83966A (en) * 1986-09-26 1992-03-29 Schering Ag Amides of aminopolycarboxylic acids and pharmaceutical compositions containing them
DE3710730A1 (en) * 1987-03-31 1988-10-20 Schering Ag SUBSTITUTED COMPLEX ILLUMINATORS, COMPLEX AND COMPLEX SALTS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THEM
ES2033433T3 (en) * 1987-07-16 1993-03-16 Nycomed As PROCEDURE TO PREPARE AMINOPOLICARBOXILIC ACIDS AND THEIR DERIVATIVES.
AU617338B2 (en) * 1987-07-16 1991-11-28 Nycomed As Aminopolycarboxylic acids and derivatives thereof
DE3728525A1 (en) * 1987-08-24 1989-03-16 Schering Ag MULTI-CORE SUBSTITUTED COMPLEX ILLUMINATORS, COMPLEX AND COMPLEX SALTS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THEM

Also Published As

Publication number Publication date
ATE115546T1 (en) 1994-12-15
NO902925L (en) 1991-01-02
NL300182I2 (en) 2005-08-01
DE59007987D1 (en) 1995-02-02
DD296276B5 (en) 1995-11-02
HU904040D0 (en) 1990-12-28
IE65676B1 (en) 1995-11-15
NO2005013I2 (en) 2006-06-19
ES2066113T3 (en) 1995-03-01
AU5802490A (en) 1991-01-03
UA27275C2 (en) 2000-09-15
AU637111B2 (en) 1993-05-20
JP2603357B2 (en) 1997-04-23
HK1002810A1 (en) 1998-09-18
NL300182I1 (en) 2005-06-01
JPH03215457A (en) 1991-09-20
HU210208B (en) 1995-02-28
PT94541A (en) 1991-02-08
CA2020142A1 (en) 1990-12-31
TW219356B (en) 1994-01-21
KR910000134A (en) 1991-01-29
NO179203B (en) 1996-05-20
FI102168B (en) 1998-10-30
DE122004000051I1 (en) 2005-04-21
EP0405704A2 (en) 1991-01-02
NZ234295A (en) 1993-02-25
RU2086554C1 (en) 1997-08-10
IE902299L (en) 1990-12-30
NO179203C (en) 1996-08-28
EP0405704A3 (en) 1991-03-27
IL94818A0 (en) 1991-04-15
DK0405704T3 (en) 1995-02-20
IL94818A (en) 1996-05-14
CZ277926B6 (en) 1993-06-16
ZA905129B (en) 1991-04-24
PT94541B (en) 1997-02-28
EP0405704B1 (en) 1994-12-14
CS9003174A2 (en) 1991-11-12
CA2020142C (en) 2001-04-17
DE3922005A1 (en) 1991-01-10
DE122004000051I2 (en) 2011-12-29
KR100190808B1 (en) 1999-06-01
FI903295A0 (en) 1990-06-29
HUT54622A (en) 1991-03-28
NO902925D0 (en) 1990-06-29
IE902299A1 (en) 1991-01-16

Similar Documents

Publication Publication Date Title
FI102168B1 (en) 3,6,9-Triaza-undecanoic acid derivatives and their salts
NO911345L (en) DTPA MONOAMIDES, PREPARATIONS CONTAINING THE COMPOUNDS, AND USE AND PROCEDURES FOR THE PREPARATION OF THE COMPOUNDS
ATE124405T1 (en) 1,4,7,10-TETRAAZACYCLODODECAN BUTYLTRIOLS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS CONTAINING SAME.
NO914356D0 (en) MONO N-SUBSTITUTED 1,4,7,10-TETRAAZACYCLODODECAN DERIVATES
ES2073006T3 (en) SEQUESTERS ASSOCIATED WITH CASCADA POLYMERS, THEIR COMPLEXES AND CONJUGATES, PROCESS FOR THEIR OBTAINING AND THE PHARMACEUTICAL PREPARATIONS THAT CONTAIN THEM.
DK0712853T3 (en) pyrazole
DK0448035T3 (en) Oleandomycinoximes, process for their preparation and use thereof

Legal Events

Date Code Title Description
FG Patent granted

Owner name: SCHERING AKTIENGESELLSCHAFT

SPCF Supplementary protection certificate application filed
PC Transfer of assignment of patent

Owner name: AVENTIS INC

SPCG Supplementary protection certificate granted

Spc suppl protection certif: NUMBER:226

PC Transfer of assignment of patent

Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT

Free format text: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT